Tocilizumab
Catalogue number:
HY-P9917-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
Cancer-Kinase/protease
Target:
Interleukin Related
Alternative Names:
Anti-Human IL6R, Humanized Antibody; RG-1569; rhPM-1
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis[1]. Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease)[4].